KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Assets: 2011-2024

Historic Return on Assets for TherapeuticsMD (TXMD) over the last 14 years, with Dec 2024 value amounting to 0.00%.

  • TherapeuticsMD's Return on Assets fell 1.00% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year decrease of 1.00%. This contributed to the annual value of 0.00% for FY2024, which is 4.00% up from last year.
  • As of FY2024, TherapeuticsMD's Return on Assets stood at 0.00%, which was up 108.27% from -0.04% recorded in FY2023.
  • TherapeuticsMD's Return on Assets' 5-year high stood at 0.85% during FY2022, with a 5-year trough of -0.82% in FY2020.
  • In the last 3 years, TherapeuticsMD's Return on Assets had a median value of 0.00% in 2024 and averaged 0.27%.
  • Its Return on Assets has fluctuated over the past 5 years, first soared by 138bps in 2022, then plummeted by 89bps in 2023.
  • Over the past 5 years, TherapeuticsMD's Return on Assets (Yearly) stood at -0.82% in 2020, then increased by 29bps to -0.53% in 2021, then surged by 138bps to 0.85% in 2022, then crashed by 89bps to -0.04% in 2023, then rose by 4bps to 0.00% in 2024.